Inactivation of PI3K-C2α deregulates cell death pathways and sensitizes to endotoxic shock

Y York Posor (Department of Oncology, University College London (UCL) Cancer Institute, University College London) S Sarah E. Conduit W Wayne Pearce (Department of Oncology, University College London (UCL) Cancer Institute, University College London) D Daniele Morelli (Department of Oncology, University College London (UCL) Cancer Institute, University College London) G Georgia Constantinou (Department of Oncology, University College London (UCL) Cancer Institute, University College London) M Maria Whitehead (Department of Oncology, University College London (UCL) Cancer Institute, University College London) N Neil J. Sebire (National Institute for Health and Care Research Great Ormond Street Hospital (NIHR GOSH) Biomedical Research Centre at) C Cheryl L. Scudamore (Exepathology) N Nieves Peltzer (Center for Molecular Medicine Cologne, University of Cologne) H Henning Walczak B Bart Vanhaesebroeck

Abstract

The organismal roles of the class II PI3K isoform PI3K-C2α remain poorly understood. Recent studies have found PI3K-C2α to promote arterial thrombosis and breast cancer metastasis, generating interest in this kinase as a drug target, with small molecule PI3K-C2α inhibitors now available. However, the consequences of systemic PI3K-C2α inactivation in the nondiseased, postnatal state are largely unknown. Here, we show that induction of genetic PI3K-C2α inactivation in adult mice is well tolerated, without adverse effects on normal physiology. Surprisingly, however, mice with inactive PI3K-C2α display strong sensitization to challenge with bacterial lipopolysaccharide (LPS), a model of endotoxic shock. This sensitization is recapitulated by vascular endothelial-specific deletion of PI3K-C2α. Furthermore, sensitization to LPS can be fully rescued by disabling extrinsic induction of cell death by combined caspase-8- and RIPK3 deficiency. These observations validate the tolerability of systemic PI3K-C2α inhibition in principle but reveal an unexpected role for PI3K-C2α in the regulation of extrinsic cell death pathways.

Article Details

Volume / Issue Vol. 122, Issue 29
Published July 22, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (11)

Y

York Posor

Department of Oncology, University College London (UCL) Cancer Institute, University College London

S

Sarah E. Conduit

W

Wayne Pearce

Department of Oncology, University College London (UCL) Cancer Institute, University College London

D

Daniele Morelli

Department of Oncology, University College London (UCL) Cancer Institute, University College London

G

Georgia Constantinou

Department of Oncology, University College London (UCL) Cancer Institute, University College London

M

Maria Whitehead

Department of Oncology, University College London (UCL) Cancer Institute, University College London

N

Neil J. Sebire

National Institute for Health and Care Research Great Ormond Street Hospital (NIHR GOSH) Biomedical Research Centre at

C

Cheryl L. Scudamore

Exepathology

N

Nieves Peltzer

Center for Molecular Medicine Cologne, University of Cologne

H

Henning Walczak

B

Bart Vanhaesebroeck